On this week’s Tech Nation, with the 44th Annual J.P. Morgan Healthcare Conference around the corner, we delve into three ongoing efforts in biotech. Moira speaks with Cyriac Roeding and Dr David Suhy, Co-Founders of Earli, about their innovative approach to treating solid tumour cancer. Then, Ketan Mehta of Tris Pharma discusses the potential of a euphoria-suppressing opioid. And Neil Klompas of Augurex Life Sciences talks about a new diagnostic for patients with chronic back pain that pinpoints an easily-missed form of arthritis.

BTN TITLE: Can Cancer Cells be Turned Against Themselves?

This week on BioTech Nation, Moira speaks with Cyriac Roeding and Dr David Suhy, Co-Founders of Earli, about an innovative new approach to solid tumour cancer. They discuss their effort to turn the cancer cells inside solid tumours into factories that produce their own cancer-fighting therapies.

On this week’s Tech Nation, Moira speaks with author and environmental thought leader Paul Hawken to discuss his latest book, "Carbon: The Book of Life", about the invisible forces shaping our planet and the actions that can transform our future. He challenges us to rethink climate, commerce, and our own beliefs.

On this week’s Tech Nation, Moira speaks with Dr Christopher Summerfield, Professor of Cognitive Science at the University of Oxford and author of "These Strange New Minds … How AI Learned to Talk and What It Means," on how AI is changing our world. Then, Professor Niels Riedemann, Co-Founder & CEO of InflaRx, explains how the body’s immune system sometimes turns against itself and what can be done to prevent it.